-Scroll.in The council chief wrote to 12 institutions asking them to enroll participants in the trials by July 7. Four days after India’s first indigenous vaccine candidate for Covid-19 was granted approval for human clinical trials by the drug regulator, the Indian Council of Medical Research on Thursday said that it wanted to “launch the vaccine for public health use latest by August 15”. On July 2, the council’s director-general Balram Bhargava wrote...
More »SEARCH RESULT
Total Matching Records found : 190
FIR against Baba Ramdev, others on COVID-19 cure claim
-The Hindu Claims made without approval from Ayush Ministry Police have registered a First Information Report against yoga guru Ramdev and four others for allegedly conspiring to sell a fake Ayurveda medicine with the misleading claim to cure COVID-19 following clinical trials on some patients. The FIR said the claim had been made without getting the Union AYUSH Ministry's approval. The others named in the FIR were Acharya Balkrishna CEO of Ramdev-promoted Patanajali...
More »Coronavirus: China trial found no benefit in HIV drugs, says study -Abantika Ghosh
-The Indian Express At 22.1 per cent, the mortality reported in the trial was substantially higher than the 11 per cent to 14.5 per cent mortality reported in initial studies of patients hospitalised with novel coronavirus (COVID-19), according to a study. The results of a 199-subject trial in China on the efficacy of HIV drugs Lopinavir and Ritonavir that India was looking at eagerly, has come out negative. At 22.1 per cent, the...
More »Vital additions to empirical research -Maitreesh Ghatak
-The Hindu Despite limitations, the use of randomised control trials has led to a paradigm shift in development policy evaluation If Rip Van Winkle was an academic economist and woke up from a two-decade long sleep this week, he would be baffled by the news of the Nobel Prize in Economics this year awarded to Abhijit Banerjee, Esther Duflo, and Michael Kremer for pioneering the use of randomised control trials (RCTs) in...
More »Explainer: What Abhijit Banerjee, Esther Duflo, Michael Kremer won the Economics Nobel for -Jahnavi Sen and Kabir Agarwal
-TheWire.in All three winners argue that using randomised control trials can lead to better public policy interventions. New Delhi: The 2019 Nobel Prize for economics has been awarded to three economists who have focused on framing policies by first measuring the outcomes of alternative interventions on randomly chosen samples from a target population. Abhijit Banerjee, Esther Duflo and Michael Kremer have all worked on using this method to argue that randomised control trials...
More »
